Intramuscular Injection of Adenoviral Hepatocyte Growth Factor at a Distal Site Ameliorates Dextran Sodium Sulfate-induced Colitis in Mice

Overview

Journal Int J Mol Med

Specialty Genetics

Date 2014 Mar 8

PMID 24604303

Citations 9

Authors

Kentaro Yuge

Tomoyuki Takahashi

Ngin Cin Khai

Kazuko Goto

Takako Fujiwara

Hisayoshi Fujiwara

Ken-Ichiro Kosai

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel disease (IBD) severely affects the quality of life of patients. At present, there is no clinical solution for this condition; therefore, there is a need for innovative therapies for IBD. Hepatocyte growth factor (HGF) exerts various biological activities in various organs. However, a clinically applicable and effective HGF-based therapy for IBD has yet to be developed. In this study, we examined the therapeutic effect of injecting an adenoviral vector encoding the human HGF gene (Ad.HGF) into the hindlimbs of mice with dextran sodium sulfate (DSS)-induced colitis. Plasma levels of circulating human HGF (hHGF) were measured in injected mice. The results showed that weight loss and colon shortening were significantly lower in Ad.HGF-infected mice as compared to control (Ad.LacZ-infected) colitic mice. Additionally, inflammation and crypt scores were significantly reduced in the entire length of the colon, particularly in the distal section. This therapeutic effect was associated with increased cell proliferation and an antiapoptotic effect, as well as a reduction in the number of CD4+ cells and a decreased CD4/CD8 ratio. The levels of inflammatory, as well as Th1 and Th2 cytokines were higher in Ad.HGF-infected mice as compared to the control colitic mice. Thus, systemically circulating hHGF protein, produced by an adenovirally transduced hHGF gene introduced at distal sites in the limbs, significantly ameliorated DSS-induced colitis by promoting cell proliferation (i.e., regeneration), preventing apoptosis, and immunomodulation. Owing to its clinical feasibility and potent therapeutic effects, this method may be developed into a clinical therapy for treating IBD.

Citing Articles

Inflammatory proteins may mediate the causal relationship between gut microbiota and inflammatory bowel disease: A mediation and multivariable Mendelian randomization study.

Huang Y, Zheng J, Shi Z, Chen H, Wang X, Kong F Medicine (Baltimore). 2024; 103(25):e38551.

PMID: 38905376 PMC: 11191895. DOI: 10.1097/MD.0000000000038551.

Protective Effect and Mechanisms of Eckol on Chronic Ulcerative Colitis Induced by Dextran Sulfate Sodium in Mice.

Liao M, Wei S, Hu X, Liu J, Wang J Mar Drugs. 2023; 21(7).

PMID: 37504907 PMC: 10381161. DOI: 10.3390/md21070376.

Hepatocyte growth factor ameliorates dextran sodium sulfate‑induced colitis in a mouse model by altering the phenotype of intestinal macrophages.

Fujino Y, Kanmura S, Morinaga Y, Kojima I, Maeda N, Tanaka A Mol Med Rep. 2023; 27(3).

PMID: 36799161 PMC: 9942250. DOI: 10.3892/mmr.2023.12957.

Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy.

Watanabe M, Nishikawaji Y, Kawakami H, Kosai K Viruses. 2021; 13(12).

PMID: 34960772 PMC: 8706629. DOI: 10.3390/v13122502.

Anti-inflammatory effect of HGF responses to oral traumatic ulcers using an HGF-Tg mouse model.

Wang X, Yan L, Tang Y, He X, Zhao X, Liu W Exp Anim. 2021; 71(2):204-213.

PMID: 34819402 PMC: 9130041. DOI: 10.1538/expanim.21-0141.

References

Thaler F, Michalopoulos G . Hepatopoietin A: partial characterization and trypsin activation of a hepatocyte growth factor. Cancer Res. 1985; 45(6):2545-9. View

Tahara Y, Ido A, Yamamoto S, Miyata Y, Uto H, Hori T . Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther. 2003; 307(1):146-51. DOI: 10.1124/jpet.103.054106. View

Li Y, Takemura G, Kosai K, Takahashi T, Okada H, Miyata S . Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Circ Res. 2004; 95(6):627-36. DOI: 10.1161/01.RES.0000141528.54850.bd. View

Matsuno M, Shiota G, Umeki K, Kawasaki H, Kojo H, Miura K . Clinical evaluation of hepatocyte growth factor in patients with gastrointestinal and pancreatic diseases with special reference to inflammatory bowel disease. Res Commun Mol Pathol Pharmacol. 1997; 97(1):25-37. View

Srivastava M, Zurakowski D, Cheifetz P, Leichtner A, Bousvaros A . Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001; 33(5):548-53. DOI: 10.1097/00005176-200111000-00007. View

Oh K, Iimuro Y, Takeuchi M, Kaneda Y, Iwasaki T, Terada N . Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model. Am J Physiol Gastrointest Liver Physiol. 2004; 288(4):G729-35. DOI: 10.1152/ajpgi.00438.2004. View

Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A . Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989; 342(6248):440-3. DOI: 10.1038/342440a0. View

Numata M, Ido A, Moriuchi A, Kim I, Tahara Y, Yamamoto S . Hepatocyte growth factor facilitates the repair of large colonic ulcers in 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats. Inflamm Bowel Dis. 2005; 11(6):551-8. DOI: 10.1097/01.mib.0000164192.71381.5c. View

Ortega-Cava C, Ishihara S, Kawashima K, Rumi M, Kazumori H, Adachi K . Hepatocyte growth factor expression in dextran sodium sulfate-induced colitis in rats. Dig Dis Sci. 2002; 47(10):2275-85. DOI: 10.1023/a:1020195513193. View

10.

Setoyama H, Ido A, Numata M, Moriuchi A, Yamaji N, Tamai T . Repeated enemas with hepatocyte growth factor selectively stimulate epithelial cell proliferation of injured mucosa in rats with experimental colitis. Life Sci. 2011; 89(7-8):269-75. DOI: 10.1016/j.lfs.2011.06.019. View

11.

Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane P . Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol. 1996; 180(2):152-9. DOI: 10.1002/(SICI)1096-9896(199610)180:2<152::AID-PATH649>3.0.CO;2-Y. View

12.

Matsumoto K, Nakamura T . Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun. 1997; 239(3):639-44. DOI: 10.1006/bbrc.1997.7517. View

13.

Okabe Y, Kusaga A, Takahashi T, Mitsumasu C, Murai Y, Tanaka E . Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome. Brain Res. 2010; 1360:17-27. DOI: 10.1016/j.brainres.2010.08.090. View

14.

Burger D, Travis S . Conventional medical management of inflammatory bowel disease. Gastroenterology. 2011; 140(6):1827-1837.e2. DOI: 10.1053/j.gastro.2011.02.045. View

15.

Miyazawa K, Tsubouchi H, Naka D, Okigaki M, Arakaki N, Nakayama H . Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun. 1989; 163(2):967-73. DOI: 10.1016/0006-291x(89)92316-4. View

16.

Chen S, Chen X, Wang Y, Kosai K, Finegold M, Rich S . Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci U S A. 1995; 92(7):2577-81. PMC: 42261. DOI: 10.1073/pnas.92.7.2577. View

17.

Shiota G, Kawasaki H, Nakamura T, SCHMIDT E . Characterization of double transgenic mice expressing hepatocye growth factor and transforming growth factor alpha. Res Commun Mol Pathol Pharmacol. 1995; 90(1):17-24. View

18.

KANAUCHI O, Nakamura T, Agata K, Mitsuyama K, Iwanaga T . Effects of germinated barley foodstuff on dextran sulfate sodium-induced colitis in rats. J Gastroenterol. 1998; 33(2):179-88. DOI: 10.1007/s005350050067. View

19.

Chen P, Kovesdi I, Bruder J . Effective repeat administration with adenovirus vectors to the muscle. Gene Ther. 2000; 7(7):587-95. DOI: 10.1038/sj.gt.3301137. View

20.

Ito W, Takeda M, Tanabe M, Kihara J, Kato H, Chiba T . Anti-allergic inflammatory effects of hepatocyte growth factor. Int Arch Allergy Immunol. 2008; 146 Suppl 1:82-7. DOI: 10.1159/000126067. View